BD (Becton, Dickinson and Company), a leading global medical technology company, and BioTechnical Institute (BTI), a nonprofit community organization, today announced that Robert Fauvie, vice president of global operations for BD Integrated Diagnostic Solutions, will join the BTI Board of Directors.
As a member of the BTI Board of Directors, Fauvie will help develop and reinforce relationships to continue BTI’s efforts to provide tuition-free, high-caliber, training to help those who are under- or unemployed to become lab workers in the state’s rapidly expanding life sciences sector.
“BD’s involvement with BTI has been invaluable in helping us to thrive and continue to meet workforce needs in Baltimore,” said Dr. Brandy Carter, BTI executive director. “We look forward to leveraging Rob’s expertise in global life sciences operations to further support our local efforts.”
At BD, Fauvie is responsible for setting and implementing the strategic direction for Operations as well as for the daily execution and total performance of our IDS manufacturing plants worldwide, including at the BD Integrated Diagnostic Solutions headquarters in Sparks, M.D., overseeing the manufacture and distribution of thousands of diagnostic instruments and millions of assays and medical devices each year.
“We’ve been part of the Maryland community for nearly 70 years and are proud to support the BTI mission to train and place entry-level biotechnicians right here in our state. Our products, developed and manufactured here in Maryland, are exported globally from our Sparks distribution center, serving millions of patients around the world,” said Fauvie. “BD innovations have supported those on the frontlines in every type of healthcare setting since 1897, and our collaboration with BTI is just one of the ways we’re creating a future of advancing the world of health.”
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.
About BTI
For more than two decades, the Biotechnical Institute of Maryland (BTI) has led the way in providing tuition-free, high-caliber, scientific training to help those who are under-or unemployed develop professional laboratory skills and develop careers in the state’s rapidly expanding biotechnology sector. We have a rigorous and relevant curriculum developed in partnership with life sciences employers. BTI has proven to be a critical resource in developing a highly skilled workforce for the economically vital life sciences industry in Maryland. Today BTI’s funders include private donors and foundations, government agencies, and life sciences employers. Visit btiworks.org to learn more.
